Landmark Nature Medicine Study Reports Promising New Treatment Reduces Suffering in Sanfilippo syndrome
June 21, 2024 08:00 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, June 21, 2024 (GLOBE NEWSWIRE) -- As a neurodegenerative disease characterized by childhood onset dementia, Sanfilippo syndrome causes immense suffering in many ways, including...
TLI Investigator Dr. Marianne Gausche-Hill Co-authors New Study Revealing Cost-Effectiveness of Pediatric Readiness in Emergency Departments
June 11, 2024 10:34 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, June 11, 2024 (GLOBE NEWSWIRE) -- A groundbreaking study published in the Journal of the American College of Emergency Physicians Open demonstrates that adhering to national...
Lundquist Investigator Dr. Ashraf Ibrahim Is the Lead Author in the Landmark Study on Pioneering Oral Fungal Infection Treatment Showing Promise in Preclinical Trials
April 30, 2024 08:00 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, April 30, 2024 (GLOBE NEWSWIRE) -- A novel oral amphotericin B (MAT2203) developed by Matinas BioPharma for treatment of invasive mucormycosis (IM) and other deadly invasive...
The Lundquist Institute Receives $2.6 Million Grant from U.S. Army Medical Research Acquisition Activity to Develop Wearable Biosensors
April 24, 2024 20:32 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, April 24, 2024 (GLOBE NEWSWIRE) -- The U.S. Army Medical Research Acquisition Activity (USAMRAA) has awarded The Lundquist Institute (TLI) a four-year grant totaling...
Lundquist Investigator Dr. Yoshihara Awarded $3 Million NIH R01 Grant for Diabetes Stem Cell Therapy Research
April 01, 2024 17:52 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, April 01, 2024 (GLOBE NEWSWIRE) -- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health, has granted...
TLI Investigator Dr. Nicholas Jenzjowsky Receives NIH/NIAID Grant to Investigate the Neural Regulation of Asthma
March 20, 2024 17:24 ET
|
The Lundquist Institute for Biomedical Innovation
Los Angeles, California, March 20, 2024 (GLOBE NEWSWIRE) -- In a significant stride for respiratory medicine, Lundquist Institute (TLI) investigator Nicholas Jendzjowsky, PhD, has been awarded a...
TLI Investigator Dr. Wei Yan Named Editor-in-Chief of the Andrology Journal
March 18, 2024 14:46 ET
|
The Lundquist Institute for Biomedical Innovation
Los Angeles, California, March 18, 2024 (GLOBE NEWSWIRE) -- The Lundquist Institute is proud to announce that Wei Yan, MD, PhD, a distinguished professor at the David Geffen School of Medicine at...
Lundquist Institute Investigator Dr. Loren Miller to Receive 2024 Top Ten Clinical Research Achievement Award from the Clinical Research Forum
February 14, 2024 19:23 ET
|
The Lundquist Institute for Biomedical Innovation
Los Angeles, California, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI) is pleased to announce that Lundquist Investigator...
CORRECTION: Lundquist Investigator Dr. Loren Miller Is the Lead Author of the “Universal Decolonization” Study Published in the New England Journal of Medicine
October 11, 2023 13:04 ET
|
The Lundquist Institute for Biomedical Innovation
Torrance, California, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The correction was changing the New English Journal of Medicine in the original headline to the New England Journal of Medicine. Nursing...
Lundquist Investigator Dr. Loren Miller Is the Lead Author of the “Universal Decolonization” Study Published in the New English Journal of Medicine
October 10, 2023 17:31 ET
|
The Lundquist Institute for Biomedical Innovation
Los Angeles, California, USA, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Nursing homes that use a chlorhexidine bathing routine to clean the skin, and an over-the-counter antiseptic to clean the nose,...